Försäljningen var stark och omsättningen ökade på samtliga marknader men vi noterar en pressad margi...
The Q2 results were largely in line with the profit warning announced on 9 June, which stated “reven...
Sales +3% vs ABGSCe, +9% vs FactSet cons. Adj. EBIT +9% vs ABGSCe, +17% vs FactSet cons.
Redeye updates its estimates following Carasent’s Q2’22 report, which was a tad weaker than anticipa...
Redeye provides its comments on the Q2 2022 report.
Redeye retains its positive stance towards Vertiseit following a Q2 report fueled with M&A growth.
Q2 report due August 18 We expect sales of SEK 13m and EBIT of -36m Share is trading at ’22e-’24e E...
Q2 sales growth of 1% y-o-y EBIT down 8-6% for ’22e-‘24e Business with Russia on pause for now Q2: S...
We have lowered our 2022e group sales by 9%, following a weaker-than-expected quarter for PET foam, ...
Minskad omsättning i Q4 men bruttomarginalen stärks Omsättningen i Q4 uppgick till EUR 69 m (83) mot...
Redeye provides its initial thoughts on the Q2 2022 report.
We see Eltel’s earnings are to decline this year as H1 cost challenges will continue to burden H2 re...
New pilot plant lays foundation for licensing agreements NEX-18 programme pause pushes approvals to ...
Redeye views the Q2 report as confirmation that OXE Marine is making good progress.
Redeye updates on Evolution post Q2-results which came in slightly lower than expected.
Redeye raises its Base Case and forecasts for Hanza following its Q2 report showing strong momentum,...
Q2 sales growth of 18% y-o-y Divestment of German operations behind sales revisions Proposed name ch...
Sales and adj. EBITA 3% and 84% below ABGSCe ’22e-‘24e adj.
Kombinationen av en ökad operationell hävstång efter genomförda förvärv och ett osäkert omvärldsläge...
Redeye comments on Smart Wires updated guidance, which lowered its revenue targets for 2022 and susp...
